- Home
- IKT vs LARK Comparison
IKT vs LARK Comparison
Compare IKT & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- LARK
- Stock Information
- Founded
- IKT 2008
- LARK 1885
- Country
- IKT United States
- LARK United States
- Employees
- IKT N/A
- LARK N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- LARK Major Banks
- Sector
- IKT Health Care
- LARK Finance
- Exchange
- IKT Nasdaq
- LARK Nasdaq
- Market Cap
- IKT 168.0M
- LARK 167.5M
- IPO Year
- IKT 2020
- LARK N/A
- Fundamental
- Price
- IKT $2.00
- LARK $29.69
- Analyst Decision
- IKT Buy
- LARK
- Analyst Count
- IKT 2
- LARK 0
- Target Price
- IKT $8.00
- LARK N/A
- AVG Volume (30 Days)
- IKT 113.6K
- LARK 31.3K
- Earning Date
- IKT 05-14-2025
- LARK 04-30-2025
- Dividend Yield
- IKT N/A
- LARK 2.84%
- EPS Growth
- IKT N/A
- LARK 27.69
- EPS
- IKT N/A
- LARK 2.59
- Revenue
- IKT N/A
- LARK $60,798,000.00
- Revenue This Year
- IKT N/A
- LARK N/A
- Revenue Next Year
- IKT N/A
- LARK N/A
- P/E Ratio
- IKT N/A
- LARK $11.13
- Revenue Growth
- IKT N/A
- LARK 9.30
- 52 Week Low
- IKT $1.12
- LARK $17.53
- 52 Week High
- IKT $4.20
- LARK $31.04
- Technical
- Relative Strength Index (RSI)
- IKT 46.57
- LARK 57.31
- Support Level
- IKT $1.78
- LARK $28.40
- Resistance Level
- IKT $2.13
- LARK $31.00
- Average True Range (ATR)
- IKT 0.16
- LARK 1.20
- MACD
- IKT -0.01
- LARK -0.12
- Stochastic Oscillator
- IKT 37.61
- LARK 54.08
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About LARK Landmark Bancorp Inc.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.